These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4204771)

  • 1. An ergot alkaloid preparation (Hydergine) in the treatment of presenile brain atrophy (Alzheimer's disease): case report.
    Burian E
    J Am Geriatr Soc; 1974 Mar; 22(3):126-8. PubMed ID: 4204771
    [No Abstract]   [Full Text] [Related]  

  • 2. An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature.
    Hughes JR; Williams JG; Currier RD
    J Am Geriatr Soc; 1976 Nov; 24(11):490-7. PubMed ID: 823192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydergine for cerebral arteriosclerosis.
    Med Lett Drugs Ther; 1974 Mar; 16(5):21-2. PubMed ID: 4204775
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hydergine in the treatment of chronic psychoses].
    Bohard F; Guennoc A; Klein H; Le Borgne Y; Masanes P
    Ann Med Psychol (Paris); 1967 Mar; 125(3):438-46. PubMed ID: 4964710
    [No Abstract]   [Full Text] [Related]  

  • 5. An ergot preparation (Hydergine) for relief of symptoms of cerebrovascular insufficiency.
    Banen DM
    J Am Geriatr Soc; 1972 Jan; 20(1):22-4. PubMed ID: 4628906
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of an ergot preparation (hydergine) in the convalescent phase of stroke.
    Bochner F; Eadie MJ; Tyrer JH
    J Am Geriatr Soc; 1973 Jan; 21(1):10-7. PubMed ID: 4630036
    [No Abstract]   [Full Text] [Related]  

  • 7. An ergot alkaloid preparation (hydergine) in geriatric therapy.
    Roubicek J; Geiger C; Abt K
    J Am Geriatr Soc; 1972 May; 20(5):222-9. PubMed ID: 4623679
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical trial comparing 'Hydergine' with placebo in the treatment of cerebrovascular insufficiency in elderly patients.
    McConnachie RW
    Curr Med Res Opin; 1973; 1(8):463-8. PubMed ID: 4204090
    [No Abstract]   [Full Text] [Related]  

  • 9. An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.
    Jennings WG
    J Am Geriatr Soc; 1972 Aug; 20(8):407-12. PubMed ID: 4626496
    [No Abstract]   [Full Text] [Related]  

  • 10. [Double blind test of hydergine in the aged].
    Bargheon J
    Nouv Presse Med; 1973 Sep; 2(31):2053-5. PubMed ID: 4199834
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of aged psychotic patients with hydergine.
    Freeman H; Murray P
    Gerontol Clin (Basel); 1966; 8(5):279-84. PubMed ID: 4960136
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic findings in 23 geriatric cases treated with hydergine (clinical note)].
    Tessler D
    Hospital (Rio J); 1970 Jul; 78(1):267-70. PubMed ID: 4991827
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydergine for dementia.
    Olin J; Schneider L; Novit A; Luczak S
    Cochrane Database Syst Rev; 2001; (2):CD000359. PubMed ID: 11405961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
    Bazo AJ
    J Am Geriatr Soc; 1973 Feb; 21(2):63-71. PubMed ID: 4631704
    [No Abstract]   [Full Text] [Related]  

  • 15. Overview of clinical trials of hydergine in dementia.
    Schneider LS; Olin JT
    Arch Neurol; 1994 Aug; 51(8):787-98. PubMed ID: 8042927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Note on the use of dihydrogenated derivatives of ergotoxin (Hydergine) and their association with psychopharmacology in the treatment of aged neuropsychiatric patients].
    Bertolotti P; Spaggiari G
    Riv Sper Freniatr Med Leg Alien Ment; 1966 Oct; 90(5):1243-58. PubMed ID: 4968439
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of ergot alkaloids (hydergine) on cerebral hemodynamics and oxygen consumption in monkeys.
    Szewczykowski J; Meyer JS; Kondo A; Nomura F; Teraura T
    J Neurol Sci; 1970 Jan; 10(1):25-31. PubMed ID: 4983718
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of hydergine on the transit time of cerebral circulation in diffuse cerebral insufficiency.
    Mongeau B
    Eur J Clin Pharmacol; 1974; 7(3):169-75. PubMed ID: 4212405
    [No Abstract]   [Full Text] [Related]  

  • 19. Relieving select symptoms of the elderly.
    Nelson JJ
    Geriatrics; 1975 Mar; 30(3):133-9, 142. PubMed ID: 803912
    [No Abstract]   [Full Text] [Related]  

  • 20. Two trials comparing 'Hydergine' with placebo in the treatment of patients suffering from cerebrovascular insufficiency.
    Rehman SA
    Curr Med Res Opin; 1973; 1(8):456-62. PubMed ID: 4204089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.